Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000248870 | SCV000316033 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000321519 | SCV000414534 | benign | Familial cold autoinflammatory syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000248870 | SCV000539906 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
ARUP Laboratories, |
RCV001286445 | SCV001473016 | benign | Familial cold autoinflammatory syndrome 2 | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001286445 | SCV001725870 | benign | Familial cold autoinflammatory syndrome 2 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001286445 | SCV002026800 | benign | Familial cold autoinflammatory syndrome 2 | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000248870 | SCV004101855 | benign | not specified | 2023-11-12 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 81% of patients studied by a panel of primary immunodeficiencies. Number of patients: 78. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV004717128 | SCV005310528 | benign | not provided | criteria provided, single submitter | not provided |